Ochratoxin alpha (CED0013379)

Record Information
Version1.0
Creation Date2026-04-06 17:02:29 UTC
Update Date2026-08-18 15:02:14 UTC
SynCED IDCED0013379
Secondary Accession Numbers
  • CHEM128015
Identification
Common NameOchratoxin alpha
ClassSmall Molecule
Description
Ochratoxin alpha belongs to the benzoic acids and derivatives, a subclass of benzene and substituted derivatives within the organic compounds. It is a benzenoid with the chemical formula C11H9ClO5 and an average molecular weight of 256.64 g/mol.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC11H9ClO5
Average Molecular Mass256.640 g/mol
Monoisotopic Mass256.014 g/mol
CAS Registry Number19165-63-0
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1S/C11H9ClO5/c1-4-2-5-7(12)3-6(10(14)15)9(13)8(5)11(16)17-4/h3-4,13H,2H2,1H3,(H,14,15)/t4-/m1/s1
InChI KeyOSFWJKYWJMZKSM-SCSAIBSYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
3453.0 Log mg/kg [1900:6100]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
cancerAssociated With?Not AvailableCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC6138766
kidney diseaseAssociated With?increaseA urinary system disease that is located in the kidney. (DO)PMC8874403
kidney diseaseAssociated With?Not AvailableA urinary system disease that is located in the kidney. (DO)PMC6354945
diseaseAssociated With?Not AvailableNot AvailablePMC9239846
Toxic encephalopathyAssociated With?Not AvailableNot AvailablePMC7828551
DeathAssociated With?Not AvailableNot AvailablePMC9239846
acute kidney injuryAssociated With?Not AvailableNot AvailablePMC8228748
Reactive Oxygen SpeciesAssociated With?increaseNot AvailablePMC10798145
Exposure Sources
Source IDSourceSectorReference
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs00749CornAgriculture & land managementPMC6138766
CEDs00751FeedAgriculture & land managementPMC7705057
CEDs00755MaizeAgriculture & land managementPMC7068566
CEDs00775FeedsAgriculture & land managementPMC6354945
CEDs00823SorghumAgriculture & land managementPMC6970494
CEDs00913Soil-plant SystemsAgriculture & land managementPMC9096872
CEDs01144FoodFood, food processing & cookwarePMC9147554
CEDs01147BeerFood, food processing & cookwarePMC7074356
CEDs01148MilkFood, food processing & cookwarePMC7074356
CEDs01151FruitsFood, food processing & cookwarePMC11435247
CEDs01160CerealsFood, food processing & cookwarePMC6960266 , PMC6138766
CEDs01171MeatFood, food processing & cookwarePMC7074356
CEDs01189ChocolateFood, food processing & cookwarePMC7074356
CEDs01191CoffeeFood, food processing & cookwarePMC7074356
CEDs01231WinesFood, food processing & cookwarePMC7074356
CEDs01243Alcoholic BeveragesFood, food processing & cookwarePMC7074356
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Vascular endothelial growth factor receptor 2 structureClick to view 3D structureVascular endothelial growth factor receptor 2P35968HumansPredicted (SEA)
Prediction Confidence Score
0.301
Applicability Domain
0.308
Statistical Significance
0.149
Supporting Reference Compounds
1660
E-value
1160.03
Platelet-derived growth factor receptor alpha structureClick to view 3D structurePlatelet-derived growth factor receptor alphaP16234HumansPredicted (SEA)
Prediction Confidence Score
0.301
Applicability Domain
0.308
Statistical Significance
0.0693
Supporting Reference Compounds
519
E-value
539.339
Mitogen-activated protein kinase 1 structureClick to view 3D structureMitogen-activated protein kinase 1P28482HumansPredicted (SEA)
Prediction Confidence Score
0.298
Applicability Domain
0.302
Statistical Significance
0.0917
Supporting Reference Compounds
763
E-value
713.644
Receptor-type tyrosine-protein kinase FLT3 structureClick to view 3D structureReceptor-type tyrosine-protein kinase FLT3P36888HumansPredicted (SEA)
Prediction Confidence Score
0.298
Applicability Domain
0.308
Statistical Significance
0.1412
Supporting Reference Compounds
1274
E-value
1099.23
Vascular endothelial growth factor receptor 3 structureClick to view 3D structureVascular endothelial growth factor receptor 3P35916HumansPredicted (SEA)
Prediction Confidence Score
0.298
Applicability Domain
0.308
Statistical Significance
0.0867
Supporting Reference Compounds
687
E-value
674.797
Mast/stem cell growth factor receptor Kit structureClick to view 3D structureMast/stem cell growth factor receptor KitP10721HumansPredicted (SEA)
Prediction Confidence Score
0.297
Applicability Domain
0.302
Statistical Significance
0.1124
Supporting Reference Compounds
905
E-value
874.792
ALK tyrosine kinase receptor structureClick to view 3D structureALK tyrosine kinase receptorQ9UM73HumansPredicted (SEA)
Prediction Confidence Score
0.29
Applicability Domain
0.302
Statistical Significance
0.1089
Supporting Reference Compounds
708
E-value
847.467
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansPredicted (SEA)
Prediction Confidence Score
0.286
Applicability Domain
0.333
Statistical Significance
0.0165
Supporting Reference Compounds
174
E-value
128.451
Tyrosine-protein kinase Lck structureClick to view 3D structureTyrosine-protein kinase LckP06239HumansPredicted (SEA)
Prediction Confidence Score
0.285
Applicability Domain
0.302
Statistical Significance
0.1788
Supporting Reference Compounds
1130
E-value
1392.18
Non-receptor tyrosine-protein kinase TYK2 structureClick to view 3D structureNon-receptor tyrosine-protein kinase TYK2P29597HumansPredicted (SEA)
Prediction Confidence Score
0.283
Applicability Domain
0.302
Statistical Significance
0.1348
Supporting Reference Compounds
657
E-value
1049.33
MAP kinase-interacting serine/threonine-protein kinase 2 structureClick to view 3D structureMAP kinase-interacting serine/threonine-protein kinase 2Q9HBH9HumansPredicted (SEA)
Prediction Confidence Score
0.28
Applicability Domain
0.302
Statistical Significance
0.1218
Supporting Reference Compounds
550
E-value
948.203
Proto-oncogene tyrosine-protein kinase receptor Ret structureClick to view 3D structureProto-oncogene tyrosine-protein kinase receptor RetP07949HumansPredicted (SEA)
Prediction Confidence Score
0.279
Applicability Domain
0.302
Statistical Significance
0.1568
Supporting Reference Compounds
764
E-value
1220.91
Ephrin type-B receptor 4 structureClick to view 3D structureEphrin type-B receptor 4P54760HumansPredicted (SEA)
Prediction Confidence Score
0.279
Applicability Domain
0.302
Statistical Significance
0.0578
Supporting Reference Compounds
259
E-value
450.28
Tyrosine-protein kinase receptor UFO structureClick to view 3D structureTyrosine-protein kinase receptor UFOP30530HumansPredicted (SEA)
Prediction Confidence Score
0.279
Applicability Domain
0.299 Low confidence
Statistical Significance
0.1055
Supporting Reference Compounds
475
E-value
821.699
Hepatocyte growth factor receptor structureClick to view 3D structureHepatocyte growth factor receptorP08581HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.299 Low confidence
Statistical Significance
0.1925
Supporting Reference Compounds
934
E-value
1498.68
Carbonic anhydrase 9 structureClick to view 3D structureCarbonic anhydrase 9Q16790HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.291 Low confidence
Statistical Significance
0.0683
Supporting Reference Compounds
372
E-value
531.477
Carbonic anhydrase 12 structureClick to view 3D structureCarbonic anhydrase 12O43570HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.291 Low confidence
Statistical Significance
0.0607
Supporting Reference Compounds
332
E-value
472.545
Carbonic anhydrase 14 structureClick to view 3D structureCarbonic anhydrase 14Q9ULX7HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.291 Low confidence
Statistical Significance
0.031
Supporting Reference Compounds
172
E-value
241.41
Carbonic anhydrase 1 structureClick to view 3D structureCarbonic anhydrase 1P00915HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.291 Low confidence
Statistical Significance
0.0731
Supporting Reference Compounds
407
E-value
569.311
Click to view 3D structureCarbonic anhydrase 5A, mitochondrialP35218HumansPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.291 Low confidence
Statistical Significance
0.0316
Supporting Reference Compounds
165
E-value
245.926
Glycogen synthase kinase-3 beta structureClick to view 3D structureGlycogen synthase kinase-3 betaP49841HumansPredicted (SEA)
Prediction Confidence Score
0.272
Applicability Domain
0.299 Low confidence
Statistical Significance
0.2427
Supporting Reference Compounds
1157
E-value
1889.48
Click to view 3D structureCarbonic anhydrase 15Q99N23Mus musculusPredicted (SEA)
Prediction Confidence Score
0.272
Applicability Domain
0.291 Low confidence
Statistical Significance
0.0142
Supporting Reference Compounds
78
E-value
110.312
Insulin-like growth factor 1 receptor structureClick to view 3D structureInsulin-like growth factor 1 receptorP08069HumansPredicted (SEA)
Prediction Confidence Score
0.27
Applicability Domain
0.299 Low confidence
Statistical Significance
0.1989
Supporting Reference Compounds
785
E-value
1548.58
Click to view 3D structureCarbonic anhydrase 13Q9D6N1Mus musculusPredicted (SEA)
Prediction Confidence Score
0.268
Applicability Domain
0.291 Low confidence
Statistical Significance
0.0136
Supporting Reference Compounds
70
E-value
106.108
Prostaglandin G/H synthase 2 structureClick to view 3D structureProstaglandin G/H synthase 2P35354HumansPredicted (SEA)
Prediction Confidence Score
0.265
Applicability Domain
0.344
Statistical Significance
0.05
Supporting Reference Compounds
201
E-value
389.246
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available